Chronic Diarrhea Owing to Underlying Microscopic Colitis
1 other identifier
observational
116
1 country
1
Brief Summary
The goal of this observational study is to search for accurate diagnoses for patients with chronic diarrhea and assess the prevalence of microscopic colitis. The main question\[s\] it aims to answer \[is/are\]: Does microscopic colitis account for a significant portion of patients with chronic diarrhea? Participants will subjected to:
- Routine laboratory examination.
- Colonoscopy: A total colonoscopy will be done with visualization of the terminal ileum. Biopsies will be taken from each segment of the colon and any abnormal appearing areas, the right-sided colon (cecum, ascending colon, and transverse colon), the left-sided colon (descending colon and sigmoid colon), and the rectum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 28, 2024
CompletedFirst Posted
Study publicly available on registry
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedAugust 2, 2024
July 1, 2024
6 months
July 28, 2024
July 31, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants with Chronic Diarrhea Diagnosed with Microscopic Colitis
Diagnostic criteria for the diagnosis of microscopic colitis include increased chronic inflammatory infiltration in the lamina propria, increased intraepithelial lymphocytes (IELs), degeneration of surface epithelium, and increased mitosis in crypts.
6 weeks
Secondary Outcomes (1)
Rate of Lymphocytic and Collagenous Types of Microscopic Colitis in Individuals Experiencing Chronic Diarrhea
2 weeks
Eligibility Criteria
Patients presented with chronic diarrhea in the outpatient clinic or the inward in the Gastroenterology and Hepatology unit in the Internal Medicine Department, Zagazig University hospitals from January 2024 to January 2025
You may qualify if:
- Patients with chronic watery diarrhea
You may not qualify if:
- Infectious colitis.
- Inflammatory bowel diseases (ulcerative colitis, Crohn's disease, and indeterminate colitis).
- Systemic disease associated with chronic diarrhea, e.g. Diabetes mellitus and Thyroid disease.
- Drugs causing chronic diarrhea, e.g. antibiotics, antidepressants, and angiotensin-converting enzyme inhibitors.
- Chronic diarrhea of decreased digestion as in pancreatic insufficiency and bile acid deficiency.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig University Hospital
Zagazig, Sharqia Province, 44519, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ayman Sadek, MD
Associate Professor of Internal Medicine - Zagazig University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Internal Medicine
Study Record Dates
First Submitted
July 28, 2024
First Posted
July 31, 2024
Study Start
January 1, 2024
Primary Completion
July 1, 2024
Study Completion
January 1, 2025
Last Updated
August 2, 2024
Record last verified: 2024-07